MedTrace Logo

Home Monitor for AA Burden Detection IIT in TWN

NCT07572279 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-05-07

No results posted yet for this study

Summary

Primary Endpoint:

* Early detection rate in Atrial Arrhythmia (AA) burden
* Data transmission success rate for overall number of atrial burden collection during the monitoring period

Secondary Endpoints:

* Atrial burden occurrence at 3/6/12 months post-aATP
* Incidence of arrhythmia
* Safety: Immediate (\< 24 hours), in-hospital, 3 months, 6 months and 12 months adverse events

Conditions

  • Paroxysmal Atrial Fibrillation (PAF)
  • Atrial Flutter

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    collaborator INDUSTRY

  • National Taiwan University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07572279 on ClinicalTrials.gov